Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Express Scripts
Chinese Patent Office
Farmers Insurance
Federal Trade Commission
Colorcon
Argus Health
UBS
Accenture

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,406,906

« Back to Dashboard

Summary for Patent: 4,406,906
Title: Cerebral therapeutic agent and its use
Abstract:The invention provides pharmaceutical compositions and medicaments, useful for the treatment of cerebral disorders, wherein the active compound is 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3-(.beta.-methoxyethy l ester)-5-(isopropyl ester). Also included in the invention are methods for the use of said compositions and medicaments.
Inventor(s): Meyer; Horst (Wuppertal, DE), Bossert; Friedrich (Wuppertal, DE), Kazda; Stanislav (Wuppertal, DE), Hoffmeister; Friedrich (Wuppertal, DE), Vater; Wulf (Leverkusen, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:06/346,319
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 4,406,906

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,406,906

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2815578Apr 11, 1978

International Patents Family Members for US Patent 4,406,906

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 383271 ➤ Sign Up
Austria A262179 ➤ Sign Up
Australia 4583579 ➤ Sign Up
Australia 532623 ➤ Sign Up
Belgium 875457 ➤ Sign Up
Canada 1140853 ➤ Sign Up
Switzerland 640734 ➤ Sign Up
Switzerland 649468 ➤ Sign Up
Switzerland 649921 ➤ Sign Up
Germany 2815578 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Daiichi Sankyo
Dow
Express Scripts
Colorcon
Merck
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot